title: Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.
abstract: The compounds of sphingomyelin-ceramide-glycosphingolipid pathways have been studied as potential secondary messenger molecules in various systems, along with liver function and insulin resistance. Secondary messenger molecules act directly or indirectly to affect cell organelles and intercellular interactions. Their potential role in the pathogenesis of steatohepatitis and diabetes has been suggested. Data samples collected from patients with Gaucher's disease, who had high levels of glucocerebroside, support a role for compounds from these pathways as a messenger molecules in the pathogenesis of fatty liver disease and diabetes. The present review summarizes some of the recent data on the role of glycosphingolipid molecules as messenger molecules in various physiological and pathological conditions, more specifically including insulin resistance and fatty liver disease.
authors.affiliation: Gastroenterology and Liver Units, Department of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel ilan@hadassah.org.il.
authors.forename: Yaron
authors.initials: Y
authors.lastname: Ilan
mesh_terms: D000818:Animals; D002518:Ceramides / Q000378:metabolism*; D005234:Fatty Liver / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D005776:Gaucher Disease / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance; D015290:Second Messenger Systems; D013109:Sphingomyelins / Q000378:metabolism*
chemical_list: D002518:Ceramides; D013109:Sphingomyelins
keywords: Gaucher disease; NAFLD; NASH; glycosphingolipids; insulin resistance; β-glucosylceramide